Breast cancer is the most common malignant tumor in women worldwide and the leading cause of cancer mortality in women; survival rates have improved dramatically in recent decades thanks to the combination of early detection, trea… Read more.
3 factors with evidence, ordered from most to least effective. Information, not medical advice.
⏱ 2 min read
Breast cancer is the most common malignant tumor in women worldwide and the leading cause of female cancer mortality; survival rates have improved dramatically in recent decades thanks to the combination of early detection, multimodal treatments (surgery, radiotherapy, chemotherapy, hormone therapy, targeted therapies, immunotherapy), and improved comprehensive management. Prevention through modifiable factors has a real, though modest, margin.
Non-modifiable: female sex, age, inherited mutations (BRCA1, BRCA2, others), family history, high breast density, personal history, exposure to chest radiation in childhood/adolescence.
Modifiable (partially): - Postmenopausal obesity: significantly increases risk. - Sedentary lifestyle. - Alcohol: any amount increases risk proportionally. - Estrogen+progestin hormone replacement therapy in menopause: increases risk with prolonged use. - Oral contraceptives: minimal increase, normalized after stopping. - No breastfeeding / short breastfeeding: breastfeeding has a modest protective effect. - Tobacco: contributes modestly. - Inflammatory diet, ultra-processed foods, caloric excess.
Mammography: population screening (typically every 2 years between ages 50-69 in Spanish programs) reduces breast cancer mortality. Some programs extend to ages 45-74 or incorporate tomosynthesis. In women at high hereditary risk, intensive screening starting earlier with breast MRI.
Monthly self-examination: a useful complement for detecting changes.
Breast ultrasound: a useful complement, especially in dense breasts.
Genetic counseling: for people with a significant family history or suspicious personal history (BRCA1/2, others).
Maintain a healthy weight: especially after menopause.
Regular physical exercise: 150 min/week of moderate aerobic activity + 2-3 strength sessions. Risk reduction of 10-20% according to studies.
Mediterranean diet: supported by prospective cohorts.
Limit alcohol significantly (ideally eliminate it).
Prolonged breastfeeding: modest protective factor.
Do not smoke.
Soy phytoestrogens (traditional dietary consumption): epidemiological data associate regular, sustained consumption from an early age with lower risk, not higher. It is important to distinguish between traditional dietary consumption (probable benefit) and concentrated isoflavone supplements in women with active or recent cancer (consult an oncologist).
Vitamin D: subclinical deficiencies are associated with a worse prognosis; reasonable to correct.
Omega-3: modest support.
Assorted polyphenols (green tea, pomegranate, broccoli): extensive preclinical support, preliminary clinical data.
Curcumin, resveratrol: preclinical support, limited clinical data.
People diagnosed with breast cancer should: - Follow the recommended oncology treatment. - Maintain physical activity during and after treatment (improves prognosis). - Watch their weight, especially avoiding significant gain. - Limit alcohol. - Consult the oncology team about any supplement or nutraceutical because of possible interactions with chemotherapy, hormone therapy (especially tamoxifen, aromatase inhibitors), and radiotherapy. - Seek psychological support when appropriate. - Keep up regular oncology surveillance after finishing treatment.
Breast cancer prevention combines maintaining a healthy weight, regular exercise, limiting alcohol, a Mediterranean diet, not smoking, and taking advantage of breastfeeding when it is an option. Adherence to screening (mammography according to protocol) is the individual intervention with the greatest impact on mortality. In people at high hereditary risk, genetic counseling and intensive screening are fundamental. After a diagnosis, conventional medical treatment is the foundation; complementary interventions (lifestyle, nutrition, selected supplements) are valuable adjuncts but never substitutes.
⏱ 2 min read
Breast cancer is the most common malignant tumor in women worldwide and the leading cause of female cancer mortality; survival rates have improved dramatically in recent decades thanks to the combination of early detection, multimodal treatments (surgery, radiotherapy, chemotherapy, hormone therapy, targeted therapies, immunotherapy), and improved comprehensive management. Prevention through modifiable factors has a real, though modest, margin.
Non-modifiable: female sex, age, inherited mutations (BRCA1, BRCA2, others), family history, high breast density, personal history, exposure to chest radiation in childhood/adolescence.
Modifiable (partially): - Postmenopausal obesity: significantly increases risk. - Sedentary lifestyle. - Alcohol: any amount increases risk proportionally. - Estrogen+progestin hormone replacement therapy in menopause: increases risk with prolonged use. - Oral contraceptives: minimal increase, normalized after stopping. - No breastfeeding / short breastfeeding: breastfeeding has a modest protective effect. - Tobacco: contributes modestly. - Inflammatory diet, ultra-processed foods, caloric excess.
Mammography: population screening (typically every 2 years between ages 50-69 in Spanish programs) reduces breast cancer mortality. Some programs extend to ages 45-74 or incorporate tomosynthesis. In women at high hereditary risk, intensive screening starting earlier with breast MRI.
Monthly self-examination: a useful complement for detecting changes.
Breast ultrasound: a useful complement, especially in dense breasts.
Genetic counseling: for people with a significant family history or suspicious personal history (BRCA1/2, others).
Maintain a healthy weight: especially after menopause.
Regular physical exercise: 150 min/week of moderate aerobic activity + 2-3 strength sessions. Risk reduction of 10-20% according to studies.
Mediterranean diet: supported by prospective cohorts.
Limit alcohol significantly (ideally eliminate it).
Prolonged breastfeeding: modest protective factor.
Do not smoke.
Soy phytoestrogens (traditional dietary consumption): epidemiological data associate regular, sustained consumption from an early age with lower risk, not higher. It is important to distinguish between traditional dietary consumption (probable benefit) and concentrated isoflavone supplements in women with active or recent cancer (consult an oncologist).
Vitamin D: subclinical deficiencies are associated with a worse prognosis; reasonable to correct.
Omega-3: modest support.
Assorted polyphenols (green tea, pomegranate, broccoli): extensive preclinical support, preliminary clinical data.
Curcumin, resveratrol: preclinical support, limited clinical data.
People diagnosed with breast cancer should: - Follow the recommended oncology treatment. - Maintain physical activity during and after treatment (improves prognosis). - Watch their weight, especially avoiding significant gain. - Limit alcohol. - Consult the oncology team about any supplement or nutraceutical because of possible interactions with chemotherapy, hormone therapy (especially tamoxifen, aromatase inhibitors), and radiotherapy. - Seek psychological support when appropriate. - Keep up regular oncology surveillance after finishing treatment.
Breast cancer prevention combines maintaining a healthy weight, regular exercise, limiting alcohol, a Mediterranean diet, not smoking, and taking advantage of breastfeeding when it is an option. Adherence to screening (mammography according to protocol) is the individual intervention with the greatest impact on mortality. In people at high hereditary risk, genetic counseling and intensive screening are fundamental. After a diagnosis, conventional medical treatment is the foundation; complementary interventions (lifestyle, nutrition, selected supplements) are valuable adjuncts but never substitutes.